Literature DB >> 1505514

Three-dimensional crystal structure of recombinant murine interferon-beta.

T Senda1, T Shimazu, S Matsuda, G Kawano, H Shimizu, K T Nakamura, Y Mitsui.   

Abstract

The crystal structure of recombinant murine interferon-beta (IFN-beta) has been solved by the multiple isomorphous replacement method and refined to an R-factor of 20.5% against 2.6 A X-ray diffraction data. The structure shows a variant of the alpha-helix bundle with a new chain-folding topology, which seems to represent a basic structural framework of all the IFN-alpha and IFN-beta molecules belonging to the type I family. Functionally important segments of the polypeptide chain, as implied through numerous gene manipulation studies carried out so far, are spatially clustered indicating the binding site(s) to the receptor(s). Comparison of the present structure with those of other alpha-helical cytokine proteins, including porcine growth hormone, interleukin 2 and interferon gamma, indicated either a topological similarity in chain folding or a similar spatial arrangement of the alpha-helices.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505514      PMCID: PMC556852          DOI: 10.1002/j.1460-2075.1992.tb05396.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.

Authors:  M J Eck; S R Sprang
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

2.  Functional significance of amino acid residues within conserved hydrophilic regions in human interferons-alpha.

Authors:  M J Tymms; B McInnes; G J Waine; B F Cheetham; A W Linnane
Journal:  Antiviral Res       Date:  1989-08       Impact factor: 5.970

3.  Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-beta.

Authors:  C Day; B Schwartz; B L Li; S Pestka
Journal:  J Interferon Res       Date:  1992-04

4.  Crystallization and preliminary X-ray investigation of a recombinant form of human gamma-interferon.

Authors:  S Vijay-Kumar; S E Senadhi; S E Ealick; T L Nagabhushan; P P Trotta; R Kosecki; P Reichert; C E Bugg
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

Review 5.  The interferon genes.

Authors:  C Weissmann; H Weber
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1986

6.  Topological distribution of four-alpha-helix bundles.

Authors:  S R Presnell; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Crystal structure of the complex of subtilisin BPN' with its protein inhibitor Streptomyces subtilisin inhibitor. The structure at 4.3 Angstroms resolution.

Authors:  S Hirono; K T Nakamura; Y Iitaka; Y Mitsui
Journal:  J Mol Biol       Date:  1979-07-15       Impact factor: 5.469

8.  Neuropoietic cytokines in the hematopoietic fold.

Authors:  J F Bazan
Journal:  Neuron       Date:  1991-08       Impact factor: 17.173

9.  Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.

Authors:  J P Priestle; H P Schär; M G Grütter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Multichain structure of the IFN-alpha receptor on hematopoietic cells.

Authors:  O R Colamonici; L M Pfeffer; F D'Alessandro; L C Platanias; S A Gregory; A Rosolen; R Nordan; R A Cruciani; M O Diaz
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

View more
  24 in total

Review 1.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.

Authors:  Zongli Li; Jennifer Julia Strunk; Peter Lamken; Jacob Piehler; Thomas Walz
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

3.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.

Authors:  C P Hill; T D Osslund; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 4.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

5.  Homology model of human interferon-alpha 8 and its receptor complex.

Authors:  M H Seto; R N Harkins; M Adler; M Whitlow; W B Church; E Croze
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

6.  Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding.

Authors:  A Wlodawer; A Pavlovsky; A Gustchina
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

7.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

9.  Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.

Authors:  Ji I Lee; Stephen P Eisenberg; Mary S Rosendahl; Elizabeth A Chlipala; Jacquelyn D Brown; Daniel H Doherty; George N Cox
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

10.  Periplasmic expression of human interferon-alpha 2c in Escherichia coli results in a correctly folded molecule.

Authors:  T Voss; E Falkner; H Ahorn; E Krystek; I Maurer-Fogy; G Bodo; R Hauptmann
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.